Program overview
Context
Indication: Breast Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Memorial Sloan Kettering Cancer Center
AC [Adriamycin (A) (also known as doxorubicin) and Cyclophosphamide (C)] Followed By Paclitaxel (P) is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Breast Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Memorial Sloan Kettering Cancer Center
Registry: 0/5
Timeline: 1/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 0/5
https://clinicaltrials.gov/study/NCT00591851
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT00591851 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |